Moderna Inc. buy Barclays PLC
Start price
16.09.24
/
50%
€62.07
Target price
16.09.25
€112.33
Performance (%)
-65.73%
End price
17.09.25
€21.27
Summary
This prediction ended on 17.09.25 with a price of €21.27. The BUY prediction by Barclays_PLC for Moderna Inc. performed very badly with a performance of -65.73%. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moderna Inc. | 3.813% | 3.813% | 126.262% |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % |
Comments by Barclays_PLC for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at Barclays PLC from $155.00 to $125.00. They now have an "overweight" rating on the stock.
Ratings data for MRNA provided by MarketBeat
In the thread Trading Moderna Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten